Notice of Intent to Award to Sole Source -Microsphere, MagPlexAvidin, reg 026, 1ml Tender

Procurement Summary

Country : USA

Summary : Notice of Intent to Award to Sole Source -Microsphere, MagPlexAvidin, reg 026, 1ml

Deadline : 06 Sep 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 106751905

Document Ref. No. : 87961

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

•The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm fixed price contract to LUMINEx CORP for purchase of Luminex Lx200 instrument.

•This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). The North American Industry Classification System code for this procurement is 541714 - Research and Development in Biotechnology (except Nanobiotechnology). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

•This notice of intent is not a request for competitive proposals; however, all responses received within three (3) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist Ruben Reyes at qmz3@cdc.gov by 12:00PM, September 06, 2024.

•The Luminex Lx200 instrument is used in the DB Lab for immunodiagnostic research activities. The supplies and reagents requested from Luminex are exclusively designed and produced by the company to be used in Luminex instruments only.

•The Luminex Lx200 instrument is used in the DB Lab for immunodiagnostic research activities. The supplies and reagents requested from Luminex are exclusively designed and produced by the company to be used in Luminex instruments only. No other products and services were considered for this request because only reagents and supplies designed and produced by Luminex may be used for the protocols that we will be running in the Luminex Platform in the DB lab.
Active Contract Opportunity
Notice ID : 87961
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : CENTERS FOR DISEASE CONTROL AND PREVENTION
Office: CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Sep 03, 2024 04:50 pm EDT
Original Response Date: Sep 06, 2024 12:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Sep 21, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance: San Juan, PR 00920 USA

Documents

 Tender Notice

A13-SAP-Sole-Source-Procurement_Luminex-Supplies.pdf